TOKYO, Nov 11 (Bernama-BUSINESS WIRE) — Kirin Holdings Company, Limited (Kirin Holdings) and Kao Corporation (Kao) will participate in the “Wakayama Health Promotion Study” cohort study*¹ led by Wakayama Medical University and compiled by the Health Promotion Research Center (HPRC), a non-profit organization, from this month. Kirin Holdings and Kao will jointly conduct research to investigate the relationship between visceral fat and the activity of plasma cytoid dendritic cells*² (pDCs), a key leader of the immune system, among others.
*1 One of the observational research methods used to examine the association between disease factors and disease onset. A group of people involved in a specific disease factor and a group of people not involved in a specific disease factor are created, and the association between factors and disease onset can be examined by calculating the incidence of the target disease in each group.
*2 Immune cells that play an important role as a key leader when bacteria or viruses enter the body. pDC activation activates various immune cells such as NK cells, T cells, and B cells to protect against viral infections.